News & Events
Dear HelpLine: Divorce
Dear HelpLine, My husband asked for a divorce, seemingly out of the blue, 2 years ago, when I was beginning to see many confusing changes with him. We eventually divorced,…
Advancing Hope: AFTD Announces 2026 Recipients of the Accelerating Drug Discovery for FTD Program
AFTD is pleased to announce the two newest recipients of research funding from the Accelerating Drug Discovery for FTD program, a partnership with the Alzheimer’s Drug Discovery Foundation. The goal…
AFTD Volunteer Appointed to California Alzheimer’s Disease and Related Conditions Advisory Committee
Family medicine physician and AFTD volunteer Jeanine Lynn Walter Misirli, MD, was appointed to the California Alzheimer’s Disease and Related Conditions Advisory Committee. As a formal member of the committee,…
Partners in FTD Care: Life After an FTD Diagnosis — What Families Need to Know
An FTD diagnosis can be overwhelming at first. Those receiving the news may initially be overwhelmed with grief, sadness, and loss. Some families are not ready to dive into FTD…
Advancing Hope: AFTD Announces 2026 Recipient of the Well-Being in FTD Pilot Grant
AFTD is pleased to announce the newest recipient of the Well-Being in FTD Pilot Grant! This program funds research focused on the well-being of persons diagnosed, families, and caregivers, and…
California Senate Passes Bipartisan Bill Expanding Neurodegenerative Disease Registry to Include Frontotemporal Degeneration
AFTD applauds the California Senate for its leadership in unanimously passing Senate Bill 1047, advancing legislation to expand the California Neurodegenerative Disease Registry to include frontotemporal degeneration (FTD). Championed by…
Volunteer Update: 2026 AFTD Ambassador Summit Fosters Connection and Collaboration
On May 2, the 2026 AFTD Ambassador Summit brought together 22 dedicated ambassadors in Renton, Washington, for a day of collaboration, strategy, and shared commitment to advancing AFTD’s mission. Designed…
Passage Bio Announces Discontinuation of upliFT-D Clinical Trial for FTD-GRN
Biotechnology firm Passage Bio announced in an emailed release that, due to issues that arose during meetings with the US Food and Drug Administration (FDA), it will be discontinuing the…